Long Term Sirolimus therapy for LAM: a real life experience

D. Elia (Milan, Italy)

Source: International Congress 2017 – Rare diseases
Session: Rare diseases
Session type: Poster Discussion
Number: 1512
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Elia (Milan, Italy). Long Term Sirolimus therapy for LAM: a real life experience. 1512

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
BT Long Term benefit: real life cases
Source: Annual Congress 2012 - Bronchial Thermoplasty: a life changing therapy for persistent asthma patients
Year: 2012

Late Breaking Abstract - Six years experience of Pirfenidone treatment in IPF patients in Crete: Real life data
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Year: 2017



Long term outcome of PAH therapy - the past and the future
Source: Annual Congress 2008 - Current and future pulmonary arterial hypertension combination therapy
Year: 2008

Effectiveness of smoking ceassation treatment in real practice: Clinical experience and long term follow-up
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010


Long term oxygen therapy (LTOT) in the real world: findings of home visiting
Source: Annual Congress 2009 - Nursing challenges at home and in hospital
Year: 2009


Long term oxygen therapy: compliance and disability among patients
Source: Eur Respir J 2002; 20: Suppl. 38, 256s
Year: 2002

Switch Omalizumab – Mepolizumab: real life experience
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019


Air travel in patients on long term oxygen therapy: Lying low or flying high?
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016

Real life experience in mTOR-inhibitors after lung transplantation
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020




Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019

CPAP versus Bilivel: Long term treatment in Obesity Hypoventilation Syndrome.
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019

Audit of long term azithromycin therapy in clinical practice
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010


Adherence to COPD controller therapy: real life setting
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019

Long term effect of doxycycline in asthma: a real world observation
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017

Participation in the ARGA study: Long term impact on asthma management
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012

Azathioprine discontinuation and medium and long term outcomes after lung transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015


Late Breaking Abstract - Prolonged azithromycin maintenance treatment in patients with COPD, a follow-up of the COLUMBUS trial
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019




Late Breaking Abstract - Short 12-month regimen with intravenous linezolid for pre-XDR TB: treatment outcomes and 24 months follow-up results
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019

Long term oxygen therapy in children
Source: Online Course 2012 - Oxygen therapy
Year: 2012

Long term efficacy and safety of omalizumab in patients with allergic asthma-A real life study
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020